Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029067944> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3029067944 endingPage "585" @default.
- W3029067944 startingPage "582" @default.
- W3029067944 abstract "Objective To investigate the therapeutic efficacy of octreotide for chylothorax after cardiothoracic surgery in infants and young children.Methods Retrospective analysis of 15 post-oper-ative chylothorax cases from July 2003 to November 2011 was done.The cases were divided into control group (n =9) and octreotide group (n =6).There was no significant difference in age,weight,time of occurrence of chylothorax between the 2 groups.The volume of chyle,the healing time and other data were analysed.Data were presented asmean differences and standard deviation (-x±s).Paired t-test was used to analysis difference between two groups and within each group.P＜0.05(or P＜0.01 )was taken as statistically significant.Results Chyle volume of control groupdecreasedin the post-treatment period after 72 hours (214.4 ± 130.2 ml/d) and 1 wcek ( 155.5 ± 86.7 ml/d)when compared to pretreatment level (256.6 ± 125.2 ml/d)[t =5.041,4.623;P=0.001,0.002].But this did not reduce furtherafter 2 and 3 weeks ( 142.3 ± 120.3 ml/d and 139.4 ± 113.4 ml/dresectively).(t =2.099,1.745:P=0.069,0.119).Treatment failure was seen in 3 cases,2 cases underwent surgical treatment and 1 case died.All 6 cases in the octreotide grouprecovered after expectant treatment.The chyle volume reduced significantlypost-treatment from 72 h (88.3 ± 22.2 ml/d); 1 week (51.2 ± 16.7 ml/d); and 2 weeks ( 19.3 ± 6.05 ml/ d ) ( t =5.227,5.549,6.638 ; P =0.003,0.003,0.002 ).When compared with the control group,significant difference in all the post-treatment time points (72 h later,1 week later,2 weeks later) could be seen (t =2.453,2.900,2.412; P =0.029,0.012,0.031 ).The healing time of treatment in two groupsalso had significant difference[control group 32.8 ± 0.75 dvsoctreotide group 25.2 ± 1.78 d] (t =2.512;P =0.028).Conclusions The use of octreotide can significantly promote the resolution of chylothorax in infants and young children.Key words: Octreotide; Chylothorax; Infants and young children" @default.
- W3029067944 created "2020-06-05" @default.
- W3029067944 creator A5009571863 @default.
- W3029067944 creator A5010550284 @default.
- W3029067944 creator A5012278873 @default.
- W3029067944 creator A5087422594 @default.
- W3029067944 date "2012-08-15" @default.
- W3029067944 modified "2023-09-22" @default.
- W3029067944 title "The clinical application of octreotidefor chylothorax after cardiothoracic surgery in infants and young children" @default.
- W3029067944 doi "https://doi.org/10.3760/cma.j.issn.0253-3006.2012.08.007" @default.
- W3029067944 hasPublicationYear "2012" @default.
- W3029067944 type Work @default.
- W3029067944 sameAs 3029067944 @default.
- W3029067944 citedByCount "0" @default.
- W3029067944 crossrefType "journal-article" @default.
- W3029067944 hasAuthorship W3029067944A5009571863 @default.
- W3029067944 hasAuthorship W3029067944A5010550284 @default.
- W3029067944 hasAuthorship W3029067944A5012278873 @default.
- W3029067944 hasAuthorship W3029067944A5087422594 @default.
- W3029067944 hasConcept C126322002 @default.
- W3029067944 hasConcept C141071460 @default.
- W3029067944 hasConcept C142724271 @default.
- W3029067944 hasConcept C160022790 @default.
- W3029067944 hasConcept C181152851 @default.
- W3029067944 hasConcept C2776297358 @default.
- W3029067944 hasConcept C2777593132 @default.
- W3029067944 hasConcept C2778373633 @default.
- W3029067944 hasConcept C2779869998 @default.
- W3029067944 hasConcept C2781025020 @default.
- W3029067944 hasConcept C71924100 @default.
- W3029067944 hasConcept C81182388 @default.
- W3029067944 hasConceptScore W3029067944C126322002 @default.
- W3029067944 hasConceptScore W3029067944C141071460 @default.
- W3029067944 hasConceptScore W3029067944C142724271 @default.
- W3029067944 hasConceptScore W3029067944C160022790 @default.
- W3029067944 hasConceptScore W3029067944C181152851 @default.
- W3029067944 hasConceptScore W3029067944C2776297358 @default.
- W3029067944 hasConceptScore W3029067944C2777593132 @default.
- W3029067944 hasConceptScore W3029067944C2778373633 @default.
- W3029067944 hasConceptScore W3029067944C2779869998 @default.
- W3029067944 hasConceptScore W3029067944C2781025020 @default.
- W3029067944 hasConceptScore W3029067944C71924100 @default.
- W3029067944 hasConceptScore W3029067944C81182388 @default.
- W3029067944 hasIssue "08" @default.
- W3029067944 hasLocation W30290679441 @default.
- W3029067944 hasOpenAccess W3029067944 @default.
- W3029067944 hasPrimaryLocation W30290679441 @default.
- W3029067944 hasRelatedWork W2347703440 @default.
- W3029067944 hasRelatedWork W2355924703 @default.
- W3029067944 hasRelatedWork W2385297866 @default.
- W3029067944 hasRelatedWork W2389990769 @default.
- W3029067944 hasRelatedWork W2392600974 @default.
- W3029067944 hasRelatedWork W2953323566 @default.
- W3029067944 hasRelatedWork W3011582500 @default.
- W3029067944 hasRelatedWork W3018269043 @default.
- W3029067944 hasRelatedWork W3028703262 @default.
- W3029067944 hasRelatedWork W3029064854 @default.
- W3029067944 hasRelatedWork W3029744507 @default.
- W3029067944 hasRelatedWork W3029890754 @default.
- W3029067944 hasRelatedWork W3030270201 @default.
- W3029067944 hasRelatedWork W3030288493 @default.
- W3029067944 hasRelatedWork W3030617253 @default.
- W3029067944 hasRelatedWork W3031056230 @default.
- W3029067944 hasRelatedWork W3031411774 @default.
- W3029067944 hasRelatedWork W3032702967 @default.
- W3029067944 hasRelatedWork W3032814030 @default.
- W3029067944 hasRelatedWork W3126005710 @default.
- W3029067944 hasVolume "33" @default.
- W3029067944 isParatext "false" @default.
- W3029067944 isRetracted "false" @default.
- W3029067944 magId "3029067944" @default.
- W3029067944 workType "article" @default.